Evaluation of the Economic and Social Burden of Chronic Obstructive Pulmonary Disease (COPD)

Biotechnology and Biotechnological Equipment- United Kingdom

doi 10.1080/13102818.2017.1335616

Full Text

Abstract

Available in

Categories

Date

June 2, 2017

Authors

Konstantin Tachkov

Maria Kamusheva

Ventsislava Pencheva

Konstantin Mitov

Publisher

Informa UK Limited

Related search

Prs37 - Economic Burden Associated With Chronic Obstructive Pulmonary Disease (Copd): A Systematic Literature Review

Value in Health

Occupational Health

English

Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Turkey: A Payor Perspective

Value in Health

Occupational Health

English

410 Estimating the Burden of Occupational Chronic Obstructive Pulmonary Disease (COPD) in the UK

Occupational and Environmental Medicine

Occupational Health

English

The Disease Burden of Chronic Obstructive Pulmonary Disease in Greece

International Journal of COPD

Respiratory Medicine

Occupational Health

English

PRS31 Economic Evaluation of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) From the Public Payer Perspective in Brazil

Value in Health

Occupational Health

English

Chronic Obstructive Pulmonary Disease (COPD) Treatment in the Elderly

English

Evaluation of Risk Factors Causing Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD) Patients.

English

Burden of Chronic Obstructive Pulmonary Disease: Healthcare Costs and Beyond

Allergy and Asthma Proceedings

Respiratory Medicine

English

Prs57 - Economic Evaluation of Single Inhaler Triple Therapy for Patients With Chronic Obstructive Pulmonary Disease (Copd) Using the Galaxy Model

Value in Health

Occupational Health

English